Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
about
Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunityPemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomesA possible role of catenin dyslocalization in pemphigus vulgaris pathogenesisHuman autoantibodies against desmoplakins in paraneoplastic pemphigusBullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy.Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicityMolecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases.Susceptibility loci revealed for bovine respiratory disease complex in pre-weaned holstein calvesAutoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenicTherapy of autoimmune bullous diseasesDistinct functions for integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomesT cell control in autoimmune bullous skin disorders.Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.Ocular involvement in pemphigus vulgaris - a retrospective study of a large Spanish cohort.Tunisian endemic pemphigus foliaceus is associated with desmoglein 1 gene polymorphism.Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirusAutoantibodies against cell adhesion molecules in pemphigus.Non-infectious diseases of the oral soft tissue: a new approach.Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases.Tissue-specific expression of the 230-kDa bullous pemphigoid antigen gene (BPAG1). Identification of a novel keratinocyte regulatory cis-element KRE3.Interferon-gamma-mediated inactivation of transcription of the 230-kDa bullous pemphigoid antigen gene (BPAG1) provides novel insight into keratinocyte differentiation.Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris.Autoantibodies to desmoplakin I and II in patients with erythema multiforme.Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases.Serum autoantibodies against epithelial cell adhesion molecules as disease biomarkers of eosinophilic esophagitis.Rituximab in pemphigus.Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination.A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximab.Augenbeteiligung beim Pemphigus vulgaris - retrospektive Studie an einer großen spanischen Kohorte.Neural nitric oxide synthase participates in pemphigus vulgaris acantholysis through upregulation of Rous sarcoma, mammalian target of rapamycin and focal adhesion kinase.Establishment of the mouse model by rabbit antiserum specific to EC1-2 or EC3-4 epitopes for studying the pathogenesis of pemphigus vulgaris.Anti-Type VII Collagen Antibodies Are Identified in a Subpopulation of Bullous Pemphigoid Patients With Relapse.Coagulation activation in autoimmune bullous diseasesAnti-Skin Specific Autoantibodies Detected by a New Immunofluorescence Multiplex Biochip Method in Patients with Autoimmune Bullous Diseases
P2860
Q24669539-463A1890-FF85-4F55-A566-0B0E5F43779DQ24674600-E335DA21-0A57-4C0D-9F38-713B4A7C9FF6Q28216007-6731552F-24E9-4959-A31A-499FA9262109Q28261726-4689C40D-EAF4-46BF-9551-B6E5D452FD14Q30706183-3643BB77-FDD5-401D-AEBB-DB811C694E70Q33751646-7745F9F2-B108-45A1-BEB2-5F7D470CB587Q33842846-EABE4E79-09F0-4417-A3C3-7D7C8C3D962AQ34245484-3D7212A3-8CD1-4EC3-9660-0120D5794FC1Q35335841-CACEBCE0-737D-4767-AE6D-72F44180DE29Q35532894-2200C787-3A83-47C1-B875-B13DC7B1667CQ35821901-B94BFD9A-3590-41D9-8461-85C98FFAC7B1Q35919150-F9262AC4-EDF0-45CD-AD04-1C79F9AD5C1AQ36224134-FB0E7FF0-6A3E-4D32-A3AD-44388994170EQ36467108-A1D72C74-4A9A-4598-AA70-E42E4E31530CQ37413586-739B7E40-F93B-4365-8333-5400F8F03C0FQ38752194-A88A4EB9-18FB-4FA4-A264-F6607851B167Q38884157-3C54CB02-28F8-4612-A8F1-EF437D03D30BQ38885224-45B38EE6-E855-4217-A2D5-4DDEA4109F86Q40209067-3DFBD60C-77AA-499E-BEB1-BBFE20D2C8B5Q40345677-2B3F33BA-F27C-4A25-8D70-112B01244C6CQ40590674-21CDB9D5-6A25-4A3E-8DA8-9213680A18D7Q40789915-EEEDA6EF-2BDE-444F-A9D5-F633662EFA56Q41005360-B055926B-8581-4B89-8BC3-E0E9F573F1AEQ42484455-9708E3A0-0C76-4396-9F94-86EECA36B592Q42487637-120A5753-9ECA-49C5-95E6-8938259052C1Q42501870-9925FA69-9C47-4C4C-A2BB-EEFCB34A2A80Q42942770-EA80F812-D8E7-4632-87A8-E0B6E21ADE91Q48127001-FF18338D-DF6D-4B8B-93D2-FC33EBACAEADQ48201641-395AD6FB-A1F1-425A-9A12-BD93CCE85145Q50075561-E58D8A26-985A-48FB-A451-6D14C5BEEDFEQ50910869-664180A5-7E82-439C-8566-A88E9C2DF381Q50935201-DC85306C-D26E-4291-BC12-2BD919B55BFAQ51065320-D1D247CD-EC26-4090-B9CF-E018123A7238Q53840764-75B2E6E9-9D8F-4002-A65D-776BA3569C8DQ54453103-81A3C0C4-36C9-4A73-B6C8-C859DC4794C4Q54469001-0C4EEB22-503B-457A-A84E-CE728EF8BF80Q54940292-A8A3BAA6-1471-4A33-9F3A-432207A881FAQ58418493-17F869DD-2D6A-48E0-8EE1-85AE86C4A016Q58985690-D1859072-3D0C-48D5-AF19-71BF85F51E79
P2860
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
@ast
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
@en
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
@nl
type
label
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
@ast
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
@en
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
@nl
prefLabel
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
@ast
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
@en
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
@nl
P2860
P356
P1476
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
@en
P2093
Stanley JR
P2860
P304
P356
10.1172/JCI114036
P407
P577
1989-05-01T00:00:00Z